» Articles » PMID: 37245717

Helicobacter Pylori Burden in the United States According to Individual Demographics and Geography: A Nationwide Analysis of the Veterans Healthcare System

Abstract

Background & Aims: There are no contemporary large-scale studies evaluating the burden of Helicobacter pylori in the United States according to detailed demographics. The primary objective was to evaluate H pylori positivity in a large national healthcare system according to individual demographics and geography.

Methods: We conducted a nationwide retrospective analysis of adults in the Veterans Health Administration who completed H pylori testing between 1999 and 2018. The primary outcome was H pylori positivity overall, as well as according to zip code-level geography, race, ethnicity, age, sex, and time period.

Results: Among 913,328 individuals (mean, 58.1 years; 90.2% male) included between 1999 and 2018, H pylori was diagnosed in 25.8%. Positivity was highest in non-Hispanic black (median, 40.2%; 95% confidence interval [CI], 40.0%-40.5%) and Hispanic (36.7%; 95% CI, 36.4%-37.1%) individuals and lowest in non-Hispanic white individuals (20.1%; 95% CI, 20.0%-20.2%). Although H pylori positivity declined in all racial and ethnic groups over the timeframe, the disproportionate burden of H pylori in non-Hispanic black and Hispanic compared with non-Hispanic white individuals persisted. Approximately 4.7% of the variation in H pylori positivity was explained by demographics, with race and ethnicity accounting for the vast majority.

Conclusions: The burden of H pylori is substantial in the United States among veterans. These data should (1) motivate research aimed at better understanding why marked demographic differences in H pylori burden persist so that mitigating interventions may be implemented and (2) guide resource allocation to optimize H pylori testing and eradication in high-risk groups.

Citing Articles

A study of the association between infection type and pancreatic cancer risk: A systematic review and meta‑analysis.

Qin C, Xu C, Zhu Z, Song X, Wang X, Xu W Oncol Lett. 2025; 29(4):174.

PMID: 39975953 PMC: 11837465. DOI: 10.3892/ol.2025.14920.


Helicobacter pylori Infection as a Cause of Dyspepsia in the Pakistani Population: An Experience From a Large Tertiary Care Center.

Shahzad S, Ahmed Tareen K, Hyder A, Ahmed I, Kauser Siddiqui M, Iqbal S Cureus. 2025; 17(1):e76776.

PMID: 39897201 PMC: 11786236. DOI: 10.7759/cureus.76776.


Association between non-insulin-based insulin resistance surrogate makers and Helicobacter pylori infection: a population-based study.

Qiu J, Yu Y, Liu D, Chen S, Wang Y, Peng J BMC Gastroenterol. 2025; 25(1):25.

PMID: 39838324 PMC: 11753134. DOI: 10.1186/s12876-025-03610-x.


Shattering the monolith: burden of gastrointestinal cancer in Asian Americans, Native Hawaiians, and Pacific Islanders in the United States.

Yoon J, Shah S, Lin J, Kim M, Itzkowitz S, Wang C Lancet Reg Health Am. 2024; 41:100954.

PMID: 39650260 PMC: 11625213. DOI: 10.1016/j.lana.2024.100954.


Salivary Antibody Responses to Potentially Waterborne and Environmentally Transmitted Infections Among Two Tribal Nations in the Southwest United States.

Wade T, Mistry J, Augustine S, Griffin S, Kobylanski J, Styles J J Epidemiol Glob Health. 2024; 14(4):1619-1632.

PMID: 39495475 PMC: 11652455. DOI: 10.1007/s44197-024-00315-4.


References
1.
Varga M, Butt J, Blot W, Le Marchand L, Haiman C, Chen Y . Racial Differences in CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States. Cancer Epidemiol Biomarkers Prev. 2020; 29(10):2084-2092. PMC: 7584346. DOI: 10.1158/1055-9965.EPI-20-0525. View

2.
El-Serag H, Kao J, Kanwal F, Gilger M, LoVecchio F, Moss S . Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018; 16(7):992-1002.e6. PMC: 6913173. DOI: 10.1016/j.cgh.2018.03.013. View

3.
Mayerle J, den Hoed C, Schurmann C, Stolk L, Homuth G, Peters M . Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA. 2013; 309(18):1912-20. DOI: 10.1001/jama.2013.4350. View

4.
Chey W, Leontiadis G, Howden C, Moss S . ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017; 112(2):212-239. DOI: 10.1038/ajg.2016.563. View

5.
Sonnenberg A, Turner K, Genta R . Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States. Am J Gastroenterol. 2020; 115(2):244-250. DOI: 10.14309/ajg.0000000000000517. View